Αποτελέσματα Αναζήτησης
This page lists active AASM clinical practice guidelines and clinical guidance statements, formerly called position papers, on the use of diagnostic and treatment options for patients with sleep disorders.
- Guideline Development Process
The AASM Guidelines Advisory Panel (GAP) reviews suggested...
- Guidelines in Development
The AASM Guidelines Advisory Panel reviews and prioritizes...
- AASM Scoring Manual
The Definitive Sleep Scoring Resource. The AASM Manual for...
- New Guideline
The AASM has published a new clinical practice guideline for...
- Guideline Development Process
The AASM has published a new clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults. These new recommendations are based on a systematic review of the literature on individual drugs commonly used to treat insomnia, and were developed using the GRADE methodology. The recommendations in this guideline define ...
15 Φεβ 2017 · In May 2016, the American College of Physicians published its own clinical practice guideline for the management of chronic insomnia. 15 This guideline makes two major recommendations. The first is that all patients with chronic insomnia receive CBT-I as the initial treatment intervention.
Pdf Summary The AASM Manual for the Scoring of Sleep and Associated Events provides guidelines for sleep scoring and monitoring. It includes a user guide, parameters to be reported for polysomnography, technical and digital specifications, and sleep staging rules for adults and children.
15 Μαρ 2017 · This guideline establishes clinical practice recommendations for the diagnosis of obstructive sleep apnea (OSA) in adults and is intended for use in conjunction with other American Academy of Sleep Medicine (AASM) guidelines on the evaluation and treatment of sleep-disordered breathing in adults.
1 Σεπ 2021 · This clinical practice guideline updates the previously published American Academy of Sleep Medicine (AASM) practice parameters on the treatment of narcolepsy and other hypersomnias of central origin 1 and reflects the current recommendations of the AASM.
It includes drugs that are FDA-approved for the treatment of insomnia, as well as several drugs commonly used to treat insomnia without an FDA indication for this condition. This guideline should be used in conjunction with other AASM guidelines on the evaluation and treatment of chronic insomnia in adults.
